Cibus (NASDAQ:CBUS) Earns “Buy” Rating from Canaccord Genuity Group

Cibus (NASDAQ:CBUS)‘s stock had its “buy” rating reissued by Canaccord Genuity Group in a research note issued on Monday,Benzinga reports. They currently have a $15.00 price objective on the stock.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Cibus in a research report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $20.00.

Cibus Stock Performance

Shares of CBUS stock traded down $0.09 during mid-day trading on Monday, hitting $1.56. The company’s stock had a trading volume of 40,235 shares, compared to its average volume of 296,327. The company has a market cap of $84.41 million, a PE ratio of -0.48 and a beta of 1.62. Cibus has a 52 week low of $1.09 and a 52 week high of $4.94. The company’s fifty day simple moving average is $1.43 and its 200-day simple moving average is $1.55.

Cibus (NASDAQ:CBUS) last announced its quarterly earnings results on Thursday, November 13th. The company reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.41) by ($0.03). Cibus had a negative return on equity of 133.90% and a negative net margin of 3,133.92%.The firm had revenue of $0.62 million during the quarter, compared to the consensus estimate of $1.39 million. On average, equities analysts anticipate that Cibus will post -2.96 earnings per share for the current year.

Hedge Funds Weigh In On Cibus

Hedge funds have recently made changes to their positions in the stock. Rockland Trust Co. bought a new position in Cibus in the 3rd quarter worth about $26,000. Blair William & Co. IL purchased a new stake in shares of Cibus in the 1st quarter worth about $28,000. Qube Research & Technologies Ltd purchased a new position in Cibus during the 2nd quarter valued at about $39,000. Warberg Asset Management LLC bought a new stake in shares of Cibus in the 2nd quarter worth approximately $41,000. Finally, FNY Investment Advisers LLC bought a new stake in Cibus in the second quarter worth $54,000. 33.81% of the stock is currently owned by hedge funds and other institutional investors.

About Cibus

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.